|
DAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22560000000738E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67006999999275E-05 |
| Normal-vs-Stage2 |
6.717000E-03 |
| Normal-vs-Stage3 |
2.567700E-02 |
| Normal-vs-Stage4 |
1.465610E-01 |
| Stage1-vs-Stage2 |
9.340600E-01 |
| Stage1-vs-Stage3 |
1.219590E-01 |
| Stage1-vs-Stage4 |
8.778400E-02 |
| Stage2-vs-Stage3 |
2.929600E-01 |
| Stage2-vs-Stage4 |
1.812640E-01 |
| Stage3-vs-Stage4 |
6.579800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.766400E-04 |
| Normal-vs-AfricanAmerican |
3.180400E-02 |
| Normal-vs-Asian |
7.042100E-03 |
| Caucasian-vs-AfricanAmerican |
3.331200E-01 |
| Caucasian-vs-Asian |
7.274600E-01 |
| AfricanAmerican-vs-Asian |
5.835000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.422600E-03 |
| Normal-vs-Female |
1.98443999999132E-05 |
| Male-vs-Female |
1.325410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.400870E-04 |
| Normal-vs-Age(41-60Yrs) |
1.417670E-04 |
| Normal-vs-Age(61-80Yrs) |
7.072300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.258100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.896600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.946300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.638200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.078990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.880600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.469770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.184400E-03 |
| Classical-VS-Follicular |
2.287600E-01 |
| Classical-VS-Other |
4.773600E-01 |
| Classical-VS-Normal |
4.32449999999696E-05 |
| Tall-VS-Follicular |
1.981930E-04 |
| Tall-VS-Other |
2.882000E-01 |
| Tall-VS-Normal |
4.058800E-01 |
| Follicular-VS-Other |
3.597400E-01 |
| Follicular-VS-Normal |
1.640050E-04 |
| Other-VS-Normal |
4.251000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.03479999999679E-05 |
| Normal-vs-N1 |
4.165000E-01 |
| N0-vs-N1 |
2.887900E-02 |
|
|
